Marksans Pharma Cash Flow Annual

Trade
BSE: 524404 | NSE: MARKSANS | ISIN: INE750C01026 | Sector: Biotechnology & Drugs
315.70 +7.15 (2.32%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 423.53337.65247.51302.16
Depreciation/ Depletion 74.2751.8544.7836.15
Non- Cash Items -18.8522.39-9.4742.13
Changesin Working Capital -248.54-174.48-183.56-201.71
Cashfrom Operating Activities 230.41237.4199.26178.74
Capital Expenditures -208.84-53.63-46.33-46.42
Other Investing Cash Flow Items Total 68.00-205.58-38.061.53
Cashfrom Investing Activities -140.84-259.21-84.39-44.90
Financing Cash Flow Items -5.17-6.07-4.22-7.99
Total Cash Dividends Paid -22.66-10.17-10.58-4.09
Issuance( Retirement)of Stock Net 0.00229.5491.16-
Issuance( Retirement)of Debt Net -40.90-15.483.16-3.21
Cashfrom Financing Activities -68.73197.8379.51-15.29
Foreign Exchange Effects 0.000.000.00-
Net Changein Cash 20.84176.0394.38118.56
Cash Interest Paid 5.176.074.227.99
Cash Taxes Paid 122.3563.0172.8648.53
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts